埃博拉病毒检测试剂（西非） 返回列表页

美国NovaBios埃博拉病毒检测试剂（西非）

广州健仑生物科技有限公司

本司长期供应埃博拉病毒检测试剂盒，其主要品牌包括美国NovaBios、广州创仑等CDC使用的进口产品，试剂盒的实验方法包括胶体金方法、ELISA方法、PCR方法等。

欢迎咨询

欢迎咨询2042552662

埃博拉病毒IgM、IgG、ELISA检测试剂、埃博拉快速检测试剂盒、

埃博拉病毒核酸检测试剂盒（荧光探针PCR）

西非工作、旅游埃博拉检测试剂盒

美国CDC使用的埃博拉诊断试剂——美国的NovaBios

美国NovaBios 埃博拉病毒检测试剂（西非）

【埃博拉简介】

埃博拉（Ebola virus）又译作伊波拉病毒。是一种十分罕见的病毒，1976年在苏丹南部和刚果（金）（旧称扎伊尔）的埃博拉河地区发现它的存在后，引起医学界的广泛关注和重视，“埃博拉”由此而得名。是一个用来称呼一群属于纤维病毒科埃博拉病毒属下数种病毒的通用术语。是一种能引起人类和灵长类动物产生埃博拉出血热的烈性传染病病毒，有很高的死亡率，在50%至90%之间，致死原因主要为中风、心肌梗塞、低血容量休克或多发性器官衰竭。

埃博拉出血热（EBHF）是由一种丝状病毒感染导致的急性出血性、动物源性传染病。1976年，埃博拉出血热在非洲的苏丹和扎伊尔暴发，病死率高达50% ～ 90% 。因该病始发于扎伊尔北部的埃博拉河流，并在该区域严重流行，故命名为埃博拉病毒，其形态学、致病性等与马尔堡病毒相似，但免疫原性有所区别。

【产品介绍】

该产品是世界卫生组织（WHO）*个批准用于埃博拉病毒检测的诊断试剂卡。不需要借助其他实验仪器设备，只需要采取几滴血清、血浆、血液样品，既可以检测，并在15分钟内就可以得知结果是否感染埃博拉病毒。该产品具有灵敏度高、操作方便、实验时间短等特点。

美国NovaBios

另一种更为精确的方法是，只计算那些同时感染了，又经历了足够长的时间，以至于要么死于病症要么恢复出院的人的zui终结果。这样的计算，自然更接近于死亡率的定义与本质。Rambaut注意到，Science上一篇研究埃博拉病毒的变异的报告中，今年五月底开始的一次地区性爆发中共确诊了78名埃博拉患者，23名存活下来。也就是说今年爆发的埃博拉病毒实际致死率应为70%。值得注意的是，这份报告由来自四个国家的五十多名奋战在一线的医疗工作者共同完成，其中五名共同作者并没有等到文章在Science上的发表。因为他们在研究与等待上线过程中已经感染了埃博拉埃博拉病毒了。
　　世界卫生组织战略部主管Christopher Dye说，目前组织正在转向这个测算方法，并在为将每一个病患的记录都整理为护理案例而努力。Dye说，“我们需要zui有效的估计。我们想知道埃博拉在这次爆发中的致死率，是否与之前在中非的几次爆发有所不同，以及目前爆发中不同的治疗方案是否有不同的效果。”
　　不过，即使这个方法依然是不够*的。在大多数疾病爆发中，由于病患并没有寻求医疗机构的帮助而导致统计案例缺失，从而带来致死率估计的偏差。Lipsitch认为，这种偏差可能是偏大的，也可能是偏小的。许多案例的病情相对温和——感染患者并不需要看医生就能自行康复——因此统计到的数据高估了实际死亡率(这正是墨西哥H1N1流感爆发时的情况，专家怀疑中东呼吸综合征爆发时也存在这种情况)。不过Lipsitch也说，温和版的埃博拉不大可能像温和版流感那样难以发现，只是考虑到这些地方整体缺少医疗条件，有可能存在一定数量的自愈患者没有被统计到。
　　另一方面，研究者注意到许多埃博拉感染者还没去到医院已经死在家中(通常还感染了其他家庭成员和照顾者)。这意味着他们的死亡并没有被计算——从而低估了致死率。
　　到底有多少未被记录的埃博拉病毒死亡病例发生，我们将永远不得而知。卫生官员正在跟踪疑似病例和可能病例，其中有许多是在被确诊为埃博拉之前已经死了的。是否将这些案例放在致死率计算中是另一个潜在的误差来源。另外，确诊测试在不同的地区有不同的模式：例如，有些地方已经做了更多的验尸测试。Lipsitch说：“怎么在这些误差中保持平衡始终是一个大问题”

美国NovaBios

我司还提供其它进口或国产试剂盒：登革热、疟疾、乙脑、寨卡、黄热病、基孔肯雅热、克锥虫病、违禁品滥用、肺炎球菌、军团菌等试剂盒以及日本生研细菌分型诊断血清、德国SiFin诊断血清、丹麦SSI诊断血清等产品。

想了解更多的NovaBios产品及服务请扫描下方二维码：

【公司名称】 广州健仑生物科技有限公司
【市场部】    杨永汉

【】 
【腾讯  】 2042552662
【公司地址】 广州清华科技园创新基地番禺石楼镇创启路63号二期2幢101-103室

Another more precise way is to calculate only those who are infected at the same time, and have experienced a long enough time to either die from the disease or to restore the final outcome of the person discharged. This calculation is naturally closer to the definition and nature of mortality. Rambaut noted that in a recent study of the latest mutation in the study of the Ebola virus, a regional outbreak began at the end of May this year, and 78 of the Ebola patients were diagnosed and 23 survived. That is the outbreak of Ebola virus this year, the actual mortality rate should be 70%. It is worth noting that the report was completed by more than 50 health workers from four countries in the first line, five of whom did not wait until the article was published in Science. Because they are in the process of research and waiting on the line has been infected with the Ebola Ebola virus.
Christopher Dye, head of the World Health Organization's strategy, says the organization is now turning to this approach and working hard to organize every patient's record into a nursing case. "We need the most effective estimate," Dye said, "and we want to know whether the lethality of Ebola in this outbreak is different from the previous outbreaks in Central Africa and whether there are different treatments in the current outbreak Different effect. "
However, even if this method is still not perfect. In most disease outbreaks, the absence of statistical cases resulted in deviations from the estimated mortality rate because the patient did not seek the help of a medical institution. Lipsitch believes that this deviation may be too large, it may be too small. In many cases the condition is relatively mild - the infected patient does not need to see a doctor to be able to recover on his own - so the statistical data overestimate the actual mortality rate (which is the case when the H1N1 flu outbreak in Mexico, experts suspected Middle East Respiratory Syndrome Outbreak when there is such a situation). But Lipsitch also said that the modest version of Ebola is unlikely to be as hard as the fluvial flu, just taking into account the overall lack of medical conditions in these places, there may be a certain number of self-healing patients have not been counted to.
On the other hand, the researchers note that many Ebola-infected people have not yet gone to the hospital that have died at home (usually also infected with other family members and caregivers). This means that their death has not been calculated - thus underestimating the lethality.
How many unrecognized Ebola virus deaths occurred in the end, we will never know. Health officials are tracking suspected cases and possible cases, many of which are already dead before being diagnosed with Ebola. Whether these cases are placed in the lethality calculation is another potential source of error. In addition, diagnostic tests have different patterns in different areas: for example, some places have done more autopsy tests. Lipsitch said: "how to balance in these errors is always a big problem"